AYTU实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally...

Stats
今日成交量	21 130.00
平均成交量	20 769.00
市值	16.76M
EPS	$0 ( 2024-02-14 )
下一个收益日期	( $-0.640 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.750
ATR14	$0.0260 (0.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Pyszczymuka Greg	Buy	208	Common Shares
2024-03-31	Pyszczymuka Greg	Sell	208	Restricted Stock Units
2023-12-31	Pyszczymuka Greg	Buy	209	Common Shares
2023-12-31	Pyszczymuka Greg	Sell	209	Restricted Stock Units
2023-09-30	Pyszczymuka Greg	Buy	208	Common Shares

INSIDER POWER
31.03
Last 94 transactions
Buy: 33 552 785 \| Sell: 39 056 468

Aytu BioScience Inc 相关性

10 最正相关
REYN	0.959
SRNGW	0.954
IBRX	0.951
VWE	0.949
HCAQ	0.948
JAGX	0.946
CHKEL	0.945
PROC	0.943
MAGS	0.942
LGMK	0.941

10 最负相关
SMAP	-0.957
OVLY	-0.955
VAQC	-0.953
IPVIU	-0.948
SY	-0.948
GENQ	-0.948
ATEC	-0.946
HPLTU	-0.944
SJ	-0.943
IGTA	-0.943

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Aytu BioScience Inc 财务报表

Annual	2023
营收:	$107.40M
毛利润:	$66.63M (62.04 %)
EPS:	$-5.11

FY	2023
营收:	$107.40M
毛利润:	$66.63M (62.04 %)
EPS:	$-5.11

FY	2022
营收:	$96.67M
毛利润:	$52.28M (54.08 %)
EPS:	$-1 499.10

FY	2021
营收:	$65.63M
毛利润:	$29.20M (44.49 %)
EPS:	$-0.174

Financial Reports:

No articles found.

Aytu BioScience Inc

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

实时更新： Aytu BioScience Inc [AYTU]

Upcoming Earnings Alert